Repetitive transcranial magnetic stimulation for treatment resistant depression
Health Technology Assessment Unit, University of Calagry
Record ID 32015000510
English
Authors' recommendations:
Inequitable access to rTMS exists within Alberta. In adults with TRD, rTMS is more effective than no treatment but the optimal protocol remains unclear. No statistically significant differences were found between rTMS and ECT; it is unclear which is most efficacious. The cost per QALY gained with rTMS compared to sham is $13,084 for response and $20,203 for remission. rTMS is more effective and less costly than ECT the majority of the time. The total fixed investment for 1 rTMS machine, including fixed operational costs, is $175,500. The marginal cost for the first session is $132.33 and the marginal cost for ongoing sessions is $47.60 (accounting for 15 minutes of nursing time). An estimate of demand is unknown. The effectiveness in youth and young adult populations is uncertain.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
https://obrieniph.ucalgary.ca/system/files/rtms-for-treatment-resistant-depression-aug-6-2014.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Transcranial Magnetic Stimulation
- Quality-Adjusted Life Years
- Cost-Benefit Analysis
Contact
Organisation Name:
HTA Unit, University of Calgary
Contact Address:
3rd Floor, TRW Building, University of Calgary, 3280 Hospital Dr NW, Calgary, Alberta, Canada, T2N 4Z6
Contact Name:
fclement@ucalgary.ca
Contact Email:
fclement@ucalgary.ca
Copyright:
University of Calgary
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.